Alkermes - ALKS Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alkermes in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ALKS shares.
View ALKS analyst ratings or view top-rated stocks.

8 brokerages have issued 1 year price objectives for Alkermes' shares. Their ALKS share price forecasts range from $25.00 to $36.00. On average, they expect the company's share price to reach $29.80 in the next twelve months. This suggests a possible upside of 17.9% from the stock's current price.
View analysts price targets for ALKS or view top-rated stocks among Wall Street analysts.

Alkermes' stock was trading at $23.26 at the beginning of 2022. Since then, ALKS shares have increased by 8.6% and is now trading at $25.27.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our ALKS earnings forecast.

Alkermes plc (NASDAQ:ALKS) released its quarterly earnings data on Wednesday, November, 2nd. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.03 by $0.01. The company had revenue of $252.36 million for the quarter, compared to analyst estimates of $271.45 million. Alkermes had a negative net margin of 11.41% and a negative trailing twelve-month return on equity of 1.10%. The company's revenue for the quarter was down 14.2% on a year-over-year basis. During the same period in the prior year, the company posted ($0.02) EPS.

Alkermes issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of $0.15-$0.33 for the period, compared to the consensus EPS estimate of $0.20. The company issued revenue guidance of $1.07 billion-$1.12 billion, compared to the consensus revenue estimate of $1.10 billion.

119 employees have rated Alkermes Chief Executive Officer Richard F. Pops on Glassdoor.com. Richard F. Pops has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alkermes investors own include Gilead Sciences (GILD), Netflix (NFLX), Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), Starbucks (SBUX), Intel (INTC), Johnson & Johnson (JNJ) and Tesla (TSLA).

Alkermes trades on the NASDAQ under the ticker symbol "ALKS."

Alkermes' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.02%), BlackRock Inc. (9.43%), State Street Corp (3.94%), Hardman Johnston Global Advisors LLC (3.49%), Renaissance Technologies LLC (3.38%) and Primecap Management Co. CA (3.25%). Insiders that own company stock include Blair Curtis Jackson, Christian Todd Nichols, Craig C Hopkinson, Craig C Hopkinson, David Joseph Gaffin, David W Anstice, Emily Peterson Alva, Iain Michael Brown, Michael J Landine, Nancy Wysenski, Richard F Pops, Shane Cooke and Wendy L Dixon.
View institutional ownership trends.

Shares of ALKS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALKS stock can currently be purchased for approximately $25.27.

Alkermes (NASDAQ:ALKS) has a market capitalization of $4.15 billion and generates $1.17 billion in revenue each year. The company earns $-48,170,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

The company employs 2,211 workers across the globe.

Alkermes' mailing address is 1 BURLINGTON ROAD CONNAUGHT HOUSE, DUBLIN L2, DUBLIN 4. The official website for the company is www.alkermes.com. The company can be reached via phone at (531) 772-8000, via email at investor_relations@alkermes.com, or via fax at 781-890-0524.